Last updated: July 10, 2026

Application No. 19/409,120

Untitled Application

Unknown

Filed

Priority

Dec 18, 2020 — EU 20215291.4 +5 more

Examiner

CHANDRA, GYAN

Art Unit

Tech Center

Novo Nordisk A/S

Assignee

Novo Nordisk Inc.

OA Round

1 (Non-Final)

Interview Optional

— +27.7% interview lift. Examiner has a relatively high allowance rate (71%); +27.7% interview lift. A written response may suffice.

Based on 993 resolved cases, 2023–2026

Examiner Intelligence

CHANDRA, GYAN View full profile →

Grants 71% — above average

Career Allowance Rate

706 granted / 993 resolved

+11.1% vs TC avg

Strong +28% interview lift

Without

With

+27.7%

Interview Lift

resolved cases with interview

Typical timeline

2y 6m

Avg Prosecution

42 currently pending

Career history

1027

Total Applications

across all art units

Statute-Specific Performance

§101

3.0%

-37.0% vs TC avg

§103

40.4%

+0.4% vs TC avg

§102

8.8%

-31.2% vs TC avg

§112

20.7%

-19.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 993 resolved cases

Prosecution Timeline

Apr 27, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/927,304

Patent 12653865

DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF

3y 6m to grant Granted Jun 16, 2026

19/067,426

Patent 12642851

SELF-ASSEMBLING NANOPARTICLES

1y 3m to grant Granted Jun 02, 2026

18/870,747

Patent 12636339

HYDROLYZED COLLAGEN FOR USE IN REDUCING BLOOD GLUCOSE

1y 5m to grant Granted May 26, 2026

18/206,963

Patent 12630608

STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

2y 11m to grant Granted May 19, 2026

18/354,452

Patent 12630803

METHOD OF INCREASING PROLIFERATION OF PANCREATIC BETA CELLS, TREATMENT METHOD, AND COMPOSITION

2y 10m to grant Granted May 19, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

71%

Grant Probability

99%

With Interview (+27.7%)

2y 6m

Median Time to Grant

Low

PTA Risk

Based on 993 resolved cases by this examiner. Grant probability derived from career allowance rate.